These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 3266754)
21. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma. Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433 [TBL] [Abstract][Full Text] [Related]
22. Human granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulates immature marrow precursors but no CFU-GM, CFU-G, or CFU-M. Bot FJ; van Eijk L; Schipper P; Löwenberg B Exp Hematol; 1989 Mar; 17(3):292-5. PubMed ID: 2645158 [TBL] [Abstract][Full Text] [Related]
23. Hematologic abnormalities of the immunodeficient mouse mutant, viable motheaten (mev). Van Zant G; Shultz L Exp Hematol; 1989 Feb; 17(2):81-7. PubMed ID: 2783574 [TBL] [Abstract][Full Text] [Related]
24. Regulation of differentiation of murine progenitor cells derived from blast cell colonies under serum-deprived conditions. Migliaccio G; Migliaccio AR; Kaushansky K; Adamson JW Exp Hematol; 1989 Feb; 17(2):110-5. PubMed ID: 2463929 [TBL] [Abstract][Full Text] [Related]
25. Opposite effect of tumor necrosis factor alpha on granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor-dependent growth of normal and leukemic hemopoietic progenitors. Piacibello W; Sanavio F; Severino A; Morelli S; Vaira AM; Stacchini A; Aglietta M Cancer Res; 1990 Aug; 50(16):5065-71. PubMed ID: 1696165 [TBL] [Abstract][Full Text] [Related]
26. Effects of murine leukemia virus infection on long-term hematopoiesis in vitro emphasized by increased survival of bone marrow cultures derived from BALB/Mo mice. Greenberger JS; Shadduck RK; Jaenisch R; Waheed A; Sakakeeny MA Cancer Res; 1981 Sep; 41(9 Pt 1):3556-65. PubMed ID: 6266658 [TBL] [Abstract][Full Text] [Related]
27. Hematopoietic growth factors in anemia of Belgrade laboratory (b/b) rats. Biljanović-Paunović L; Stojanović N; Mostarica-Stojković M; Ramić Z; Ivanović Z; Basara N; Clemons GK; Pavlović-Kentera V Exp Hematol; 1992 Dec; 20(11):1257-62. PubMed ID: 1493855 [TBL] [Abstract][Full Text] [Related]
28. Characterization of hemopoietic activities in media conditioned by a murine marrow-derived adherent cell line, B.Ad. Li CL; Culter RL; Johnson GR Exp Hematol; 1987 May; 15(4):373-81. PubMed ID: 3494626 [TBL] [Abstract][Full Text] [Related]
29. Enhanced myelopoiesis in long-term cultures of human bone marrow pretreated with recombinant granulocyte-macrophage colony-stimulating factor. Haas R; Ogniben E; Kiesel S; Hohaus S; Baumann M; Körbling M; Dörken B; Hunstein W Exp Hematol; 1989 Mar; 17(3):235-9. PubMed ID: 2645156 [TBL] [Abstract][Full Text] [Related]
30. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor. Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867 [TBL] [Abstract][Full Text] [Related]
31. Heterogeneous colony forming ability in vitro of the abnormal clone-derived granulocyte-macrophage precursors in myelodysplastic syndromes. Okuda T; Yokota S; Maekawa T; Sonoda Y; Misawa S; Takino T; Abe T Leuk Res; 1988; 12(8):687-92. PubMed ID: 3184986 [TBL] [Abstract][Full Text] [Related]
32. Bone marrow cultures and prognosis in primary myelodysplastic syndromes. Korthout M; De Bock R; van Bockstaele D; Peetermans M Leuk Res; 1990; 14(1):85-9. PubMed ID: 2304356 [TBL] [Abstract][Full Text] [Related]
33. Type-specific in vitro growth patterns of multilineage hemopoietic progenitors in myeloproliferative disorders and myelodysplastic syndromes. Sugiyama H; Yagita M; Takahashi T; Nakamura K; Iho S; Hoshino T; Imura H Nihon Ketsueki Gakkai Zasshi; 1987 Feb; 50(1):46-58. PubMed ID: 3495951 [No Abstract] [Full Text] [Related]
34. Primary bioassay of human myeloma stem cells. Hamburger A; Salmon SE J Clin Invest; 1977 Oct; 60(4):846-54. PubMed ID: 302265 [TBL] [Abstract][Full Text] [Related]
35. Granulopoiesis-supporting effects of marrow stromal cells in continuous culture from patients with primary myelofibrosis. Hotta T; Murate T; Yamao H; Yamada H; Saito H Br J Haematol; 1986 Dec; 64(4):669-73. PubMed ID: 3801318 [TBL] [Abstract][Full Text] [Related]
38. The effect of retinoids on CFU-GM from normal subjects and patients with myelodysplastic syndrome. Bailey-Wood R; May S; Jacobs A Br J Haematol; 1985 Jan; 59(1):15-20. PubMed ID: 3970848 [TBL] [Abstract][Full Text] [Related]
39. Variable growth in vitro of chromosomally different stem cells in myelodysplastic syndromes. Swolin B; Kristiansen IH; Rödjer S; Hellström-Lindberg E Leuk Res; 1993 Nov; 17(11):927-32. PubMed ID: 8231233 [TBL] [Abstract][Full Text] [Related]
40. Response to treatment in acute non-lymphatic leukaemia: prognostic value of colony forming and colony stimulating capacities of bone marrow and blood cells compared to other parameters. Beran M; Reizenstein P; Uden AM Br J Haematol; 1980 Jan; 44(1):39-50. PubMed ID: 6966502 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]